Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSC in Newly Diagnosed Chronic Graft-Versus-Host Disease
NCT02291770Phase 3Unknown
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- Oct 2014
- Primary completion
- Nov 2015
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Provacel in chronic graft-versus-host disease (cGVHD), sponsored by Guangdong Provincial People's Hospital. Status: unknown.
02
Drugs
Provacel
03
Conditions
chronic graft-versus-host disease (cGVHD)
Beyond the preview
Go deeper on NCT02291770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02291770.